These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 10900109

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of topical administration of 0.5% apraclonidine on intraocular pressure, pupil size, and heart rate in clinically normal dogs.
    Miller PE, Nelson MJ, Rhaesa SL.
    Am J Vet Res; 1996 Jan; 57(1):79-82. PubMed ID: 8720243
    [Abstract] [Full Text] [Related]

  • 3. Apraclonidine and brimonidine effects on anterior ocular and cardiovascular physiology in normal and sympathectomized monkeys.
    Gabelt BT, Robinson JC, Hubbard WC, Peterson CM, Debink N, Wadhwa A, Kaufman PL.
    Exp Eye Res; 1994 Dec; 59(6):633-44. PubMed ID: 7698258
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. False negative apraclonidine test in two patients with Horner syndrome.
    Kawasaki A, Borruat FX.
    Klin Monbl Augenheilkd; 2008 May; 225(5):520-2. PubMed ID: 18454417
    [Abstract] [Full Text] [Related]

  • 7. Comparing brimonidine 0.2% to apraclonidine 1.0% in the prevention of intraocular pressure elevation and their pupillary effects following laser peripheral iridotomy.
    Yuen NS, Cheung P, Hui SP.
    Jpn J Ophthalmol; 2005 May; 49(2):89-92. PubMed ID: 15838723
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of apraclonidine on aqueous humor dynamics in human eyes.
    Toris CB, Tafoya ME, Camras CB, Yablonski ME.
    Ophthalmology; 1995 Mar; 102(3):456-61. PubMed ID: 7891985
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of digital pupillometry for diagnosis of Horner syndrome.
    Yoo YJ, Yang HK, Hwang JM.
    PLoS One; 2017 Mar; 12(6):e0178361. PubMed ID: 28575101
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy of apraclonidine 0.5% in the diagnosis of Horner syndrome in pediatric patients under low or high illumination.
    Chen PL, Hsiao CH, Chen JT, Lu DW, Chen WY.
    Am J Ophthalmol; 2006 Sep; 142(3):469-74. PubMed ID: 16935593
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Aqueous flow is reduced by the alpha-adrenergic agonist, apraclonidine hydrochloride (ALO 2145).
    Gharagozloo NZ, Relf SJ, Brubaker RF.
    Ophthalmology; 1988 Sep; 95(9):1217-20. PubMed ID: 3062536
    [Abstract] [Full Text] [Related]

  • 16. The effect of 1% apraclonidine on intraocular pressure after cataract surgery.
    Sterk CC, Renzenbrink-Bubberman AC, van Best JA.
    Ophthalmic Surg Lasers; 1998 Jun; 29(6):472-5. PubMed ID: 9640568
    [Abstract] [Full Text] [Related]

  • 17. Topical apraclonidine in the diagnosis of suspected Horner syndrome.
    Freedman KA, Brown SM.
    J Neuroophthalmol; 2005 Jun; 25(2):83-5. PubMed ID: 15937427
    [Abstract] [Full Text] [Related]

  • 18. Topical apraclonidine testing discloses pupillary sympathetic denervation in diabetic patients.
    Koc F, Kansu T, Kavuncu S, Firat E.
    J Neuroophthalmol; 2006 Mar; 26(1):25-9. PubMed ID: 16518162
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.